News
MTPA's oral therapy Radicava (edaravone) has shown decreased functional decline and improved survival in long-term ALS trials ...
Having lived with an ALS diagnosis since 2018, Kate Nycz can tell you firsthand what it's like to slowly lose motor function for basic tasks. "My arm can get to maybe 90 degrees, but then it fatigues ...
Summary: A new study has uncovered why some motor neurons resist degeneration in ALS while others succumb. Researchers found ...
Jodi O’Donnell-Ames founded Hope Loves Company to provide support, resources, and community to children affected by ALS.
Stockhead on MSN11h
Neurizon’s ALS drug shows safety and extended survival in open-label extension study
Neurizon Therapeutics has reported positive topline results from an open-label extension study of its lead candidate NUZ-001 ...
News-Medical.Net on MSN15h
Researchers gain better understanding of how nerve cells can be protected against ALS
By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in collaboration with scientists at the Paris Brain Institute and Örebro ...
By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in ...
The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback